Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Godoy-Gijón

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Actas Dermo-Sifiliograficas|July 17, 2017
BRAF Mutation Status Concordance Between Primary Cutaneous Melanomas and Corresponding Metastases: A Review of the Latest EvidenceE Godoy-Gijón, M Yuste-Chaves, Á Santos-Briz
Actas Dermo-Sifiliograficas|July 30, 2011
[Accessory breast on the vulva]E Godoy-Gijón, M Yuste-Chaves, A Santos-Briz, et al.
Clinical and Experimental Dermatology|August 22, 2014
Facial Angiofibroma Severity Index (FASI): reliability assessment of a new tool developed to measure severity and responsiveness to therapy in tuberous sclerosis-associated facial angiofibromaR Salido-Vallejo, J Ruano, G Garnacho-Saucedo, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Actas Dermo-Sifiliograficas|July 17, 2017
BRAF Mutation Status Concordance Between Primary Cutaneous Melanomas and Corresponding Metastases: A Review of the Latest EvidenceE Godoy-Gijón, M Yuste-Chaves, Á Santos-Briz
Actas Dermo-Sifiliograficas|July 30, 2011
[Accessory breast on the vulva]E Godoy-Gijón, M Yuste-Chaves, A Santos-Briz, et al.
Clinical and Experimental Dermatology|August 22, 2014
Facial Angiofibroma Severity Index (FASI): reliability assessment of a new tool developed to measure severity and responsiveness to therapy in tuberous sclerosis-associated facial angiofibromaR Salido-Vallejo, J Ruano, G Garnacho-Saucedo, et al.
Pageof 1